Acenocoumarol
Oxytetracycline may increase the anticoagulant activities of Acenocoumarol.
Acitretin
The risk or severity of adverse effects can be increased when Oxytetracycline is combined with Acitretin.
Adapalene
The risk or severity of adverse effects can be increased when Oxytetracycline is combined with Adapalene.
Advertisement
Alitretinoin
The risk or severity of adverse effects can be increased when Oxytetracycline is combined with Alitretinoin.
Aloglutamol
Aloglutamol can cause a decrease in the absorption of Oxytetracycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
Aluminum
Aluminium can cause a decrease in the absorption of Oxytetracycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
Advertisement
Aluminum Hydroxide
Aluminum hydroxide can cause a decrease in the absorption of Oxytetracycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
aluminum hydroxide, dried (USP)
Aluminum hydroxide can cause a decrease in the absorption of Oxytetracycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
Aluminum Magnesium Silicate
Almasilate can cause a decrease in the absorption of Oxytetracycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
Advertisement
Amdinocillin
The therapeutic efficacy of Amdinocillin can be decreased when used in combination with Oxytetracycline.
Amdinocillin Pivoxil
The therapeutic efficacy of Pivmecillinam can be decreased when used in combination with Oxytetracycline.
Amoxicillin
The therapeutic efficacy of Amoxicillin can be decreased when used in combination with Oxytetracycline.
Amoxicillin Anhydrous
The therapeutic efficacy of Amoxicillin can be decreased when used in combination with Oxytetracycline.
Ampicillin
The therapeutic efficacy of Ampicillin can be decreased when used in combination with Oxytetracycline.
Ampicillin (anhydrous)
The therapeutic efficacy of Ampicillin can be decreased when used in combination with Oxytetracycline.
Atracurium
Oxytetracycline may increase the neuromuscular blocking activities of Atracurium.
Atracurium Besylate
Oxytetracycline may increase the neuromuscular blocking activities of Atracurium besylate.
Azidocillin
The therapeutic efficacy of Azidocillin can be decreased when used in combination with Oxytetracycline.
Azlocillin
The therapeutic efficacy of Azlocillin can be decreased when used in combination with Oxytetracycline.
Bacampicillin
The therapeutic efficacy of Bacampicillin can be decreased when used in combination with Oxytetracycline.
BCG Vaccine
The therapeutic efficacy of BCG vaccine can be decreased when used in combination with Oxytetracycline.
Benzylpenicilloyl polylysine
The therapeutic efficacy of Benzylpenicilloyl Polylysine can be decreased when used in combination with Oxytetracycline.
Bexarotene
The risk or severity of adverse effects can be increased when Oxytetracycline is combined with Bexarotene.
Bismuth Subcitrate
The serum concentration of Oxytetracycline can be decreased when it is combined with Bismuth Subcitrate.
Bismuth Subnitrate
Bismuth subnitrate can cause a decrease in the absorption of Oxytetracycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
Bismuth Subsalicylate
The serum concentration of Oxytetracycline can be decreased when it is combined with Bismuth Subsalicylate.
Calcium Acetate
The serum concentration of Oxytetracycline can be decreased when it is combined with Calcium Acetate.
Calcium Carbonate
Calcium Carbonate can cause a decrease in the absorption of Oxytetracycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
CALCIUM CARBONATE, PRECIPITATED
Calcium Carbonate can cause a decrease in the absorption of Oxytetracycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
Calcium Chloride
The serum concentration of Oxytetracycline can be decreased when it is combined with Calcium Chloride.
Calcium Chloride Anhydrous
The serum concentration of Oxytetracycline can be decreased when it is combined with Calcium Chloride.
Calcium Citrate
The serum concentration of Oxytetracycline can be decreased when it is combined with Calcium Citrate.
Calcium Glubionate
The serum concentration of Oxytetracycline can be decreased when it is combined with Calcium glubionate.
Calcium gluceptate
The serum concentration of Oxytetracycline can be decreased when it is combined with Calcium Gluceptate.
Calcium Gluconate
The serum concentration of Oxytetracycline can be decreased when it is combined with Calcium gluconate.
Calcium Lactate
The serum concentration of Oxytetracycline can be decreased when it is combined with Calcium lactate.
CALCIUM LEVULINATE
The serum concentration of Oxytetracycline can be decreased when it is combined with Calcium levulinate.
Carbenicillin
The therapeutic efficacy of Carbenicillin can be decreased when used in combination with Oxytetracycline.
Casein Allergenic Extract
The serum concentration of Oxytetracycline can be decreased when it is combined with Casein.
Cholestyramine Resin
Cholestyramine can cause a decrease in the absorption of Oxytetracycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
Cisatracurium
Oxytetracycline may increase the neuromuscular blocking activities of Cisatracurium.
Cloxacillin
The therapeutic efficacy of Cloxacillin can be decreased when used in combination with Oxytetracycline.
Colesevelam
Colesevelam can cause a decrease in the absorption of Oxytetracycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
Colestipol
Colestipol can cause a decrease in the absorption of Oxytetracycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
Cyclacillin
The therapeutic efficacy of Cyclacillin can be decreased when used in combination with Oxytetracycline.
Dicloxacillin
The therapeutic efficacy of Dicloxacillin can be decreased when used in combination with Oxytetracycline.
Dicumarol
Oxytetracycline may increase the anticoagulant activities of Dicoumarol.
Doxacurium Chloride
Oxytetracycline may increase the neuromuscular blocking activities of Doxacurium chloride.
Ferric Carboxymaltose
Oxytetracycline can cause a decrease in the absorption of Ferric Carboxymaltose resulting in a reduced serum concentration and potentially a decrease in efficacy.
Ferric Pyrophosphate
Oxytetracycline can cause a decrease in the absorption of Ferric pyrophosphate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Floxacillin
The therapeutic efficacy of Flucloxacillin can be decreased when used in combination with Oxytetracycline.
Fluindione
Oxytetracycline may increase the anticoagulant activities of Fluindione.
Gallamine Triethiodide
Oxytetracycline may increase the neuromuscular blocking activities of Gallamine Triethiodide.
Hydrotalcite
Hydrotalcite can cause a decrease in the absorption of Oxytetracycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
Iron
Oxytetracycline can cause a decrease in the absorption of Iron resulting in a reduced serum concentration and potentially a decrease in efficacy.
Iron Carbonyl
Oxytetracycline can cause a decrease in the absorption of Iron resulting in a reduced serum concentration and potentially a decrease in efficacy.
Iron Sucrose
The serum concentration of Oxytetracycline can be decreased when it is combined with Iron saccharate.
Iron-Dextran Complex
Oxytetracycline can cause a decrease in the absorption of Iron Dextran resulting in a reduced serum concentration and potentially a decrease in efficacy.
Isotretinoin
The risk or severity of adverse effects can be increased when Oxytetracycline is combined with Isotretinoin.
Lanthanum Carbonate
The serum concentration of Oxytetracycline can be decreased when it is combined with Lanthanum carbonate.
Magaldrate
Magaldrate can cause a decrease in the absorption of Oxytetracycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
Magnesium Carbonate
Magnesium carbonate can cause a decrease in the absorption of Oxytetracycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
Magnesium Hydroxide
Magnesium hydroxide can cause a decrease in the absorption of Oxytetracycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
Magnesium Oxide
Magnesium oxide can cause a decrease in the absorption of Oxytetracycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
Magnesium Salicylate
Magnesium salicylate can cause a decrease in the absorption of Oxytetracycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
Magnesium silicate
Magnesium silicate can cause a decrease in the absorption of Oxytetracycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
Magnesium Sulfate
Magnesium sulfate can cause a decrease in the absorption of Oxytetracycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
MAGNESIUM SULFATE ANHYDROUS
Magnesium sulfate can cause a decrease in the absorption of Oxytetracycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
Magnesium Trisilicate
Magnesium Trisilicate can cause a decrease in the absorption of Oxytetracycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
Mecamylamine
Oxytetracycline may increase the neuromuscular blocking activities of Mecamylamine.
Medrogestone
The serum concentration of Medrogestone can be decreased when it is combined with Oxytetracycline.
Methampicillin
The therapeutic efficacy of Metampicillin can be decreased when used in combination with Oxytetracycline.
Metocurine
Oxytetracycline may increase the neuromuscular blocking activities of Metocurine.
Metocurine iodide
Oxytetracycline may increase the neuromuscular blocking activities of Metocurine Iodide.
Mezlocillin
The therapeutic efficacy of Mezlocillin can be decreased when used in combination with Oxytetracycline.
Mipomersen
Oxytetracycline may increase the hepatotoxic activities of Mipomersen.
Mivacurium
Oxytetracycline may increase the neuromuscular blocking activities of Mivacurium.
Nafcillin
The therapeutic efficacy of Nafcillin can be decreased when used in combination with Oxytetracycline.
Oxacillin
The therapeutic efficacy of Oxacillin can be decreased when used in combination with Oxytetracycline.
Pancuronium
Oxytetracycline may increase the neuromuscular blocking activities of Pancuronium.
Pancuronium Bromide
Oxytetracycline may increase the neuromuscular blocking activities of Pancuronium.
Penicillin G
The therapeutic efficacy of Benzylpenicillin can be decreased when used in combination with Oxytetracycline.
penicillin G benzathine
The therapeutic efficacy of Benzathine benzylpenicillin can be decreased when used in combination with Oxytetracycline.
penicillin G procaine
The therapeutic efficacy of Procaine benzylpenicillin can be decreased when used in combination with Oxytetracycline.
Penicillin V
The therapeutic efficacy of Phenoxymethylpenicillin can be decreased when used in combination with Oxytetracycline.
Phenindione
Oxytetracycline may increase the anticoagulant activities of Phenindione.
Phenprocoumon
Oxytetracycline may increase the anticoagulant activities of Phenprocoumon.
Picosulfuric Acid
The therapeutic efficacy of Picosulfuric acid can be decreased when used in combination with Oxytetracycline.
Pipecuronium
Oxytetracycline may increase the neuromuscular blocking activities of Pipecuronium.
Piperacillin
The therapeutic efficacy of Piperacillin can be decreased when used in combination with Oxytetracycline.
Piperacillin Anhydrous
The therapeutic efficacy of Piperacillin can be decreased when used in combination with Oxytetracycline.
Pivampicillin
The therapeutic efficacy of Pivampicillin can be decreased when used in combination with Oxytetracycline.
Procaine
The therapeutic efficacy of Procaine can be decreased when used in combination with Oxytetracycline.
Propicillin
The therapeutic efficacy of Propicillin can be decreased when used in combination with Oxytetracycline.
Pyrantel
Oxytetracycline may increase the neuromuscular blocking activities of Pyrantel.
Quinapril
Quinapril can cause a decrease in the absorption of Oxytetracycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
Rapacuronium
Oxytetracycline may increase the neuromuscular blocking activities of Rapacuronium.
Rocuronium
Oxytetracycline may increase the neuromuscular blocking activities of Rocuronium.
Sodium Bicarbonate
Sodium bicarbonate can cause a decrease in the absorption of Oxytetracycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
Succinylcholine
Oxytetracycline may increase the neuromuscular blocking activities of Succinylcholine.
Sucralfate
Sucralfate can cause a decrease in the absorption of Oxytetracycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
Sucroferric Oxyhydroxide
The serum concentration of Oxytetracycline can be decreased when it is combined with Iron saccharate.
Ticarcillin
The therapeutic efficacy of Ticarcillin can be decreased when used in combination with Oxytetracycline.
Tretinoin
The risk or severity of adverse effects can be increased when Oxytetracycline is combined with Tretinoin.
Tricalcium Phosphate
The serum concentration of Oxytetracycline can be decreased when it is combined with Calcium Phosphate.
Tromethamine
Tromethamine can cause a decrease in the absorption of Oxytetracycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
Tubocurarine
Oxytetracycline may increase the neuromuscular blocking activities of Tubocurarine.
Vecuronium
Oxytetracycline may increase the neuromuscular blocking activities of Vecuronium.
Warfarin
Oxytetracycline may increase the anticoagulant activities of Warfarin.
